ong-term intake experiment of D-psicose for type 2 diabetic patients
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000027143
- Lead Sponsor
- Kagawa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients falling under D-psicose administration contraindications 2.Patients taking oral administration of HMG-CoA reductase inhibitor 3.Patients participating in other clinical trials 4.Pregnant women, maternity women, lactating women or women with the possibility of pregnancy 5.Patients who have poor glycemic control with HbA1c> 8% 6.Patients who have severe renal dysfunction (serum creatinine value> 1.5 mg / dl) 7.Patients with other serious complications 8.Other patients judged inappropriate as judged by doctors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluate the fluctuation of the value of LDL-C before and after administration of D-psicose
- Secondary Outcome Measures
Name Time Method